These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1658661)
1. Stimulus-evoked release of tritiated monoamines from rat periaqueductal gray slices in vitro and its receptor-mediated modulation. Versteeg DH; Csikós T; Spierenburg H Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):595-602. PubMed ID: 1658661 [TBL] [Abstract][Full Text] [Related]
2. The electrically stimulated release of [3H]noradrenaline from nucleus tractus solitarii slices in vitro is modulated via mu-opioid receptors. Arakawa K; De Jong W; Mulder AH; Versteeg DH Eur J Pharmacol; 1991 Jan; 192(2):311-6. PubMed ID: 1674475 [TBL] [Abstract][Full Text] [Related]
3. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610 [TBL] [Abstract][Full Text] [Related]
4. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices. Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region. Keay KA; Crowfoot LJ; Floyd NS; Henderson LA; Christie MJ; Bandler R Brain Res; 1997 Jul; 762(1-2):61-71. PubMed ID: 9262159 [TBL] [Abstract][Full Text] [Related]
6. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices. Schoffelmeer AN; Wierenga EA; Mulder AH J Neurochem; 1986 Jun; 46(6):1711-7. PubMed ID: 2422322 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Chieng B; Christie MJ Br J Pharmacol; 1994 Sep; 113(1):303-9. PubMed ID: 7812626 [TBL] [Abstract][Full Text] [Related]
8. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices. Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278 [TBL] [Abstract][Full Text] [Related]
9. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675 [TBL] [Abstract][Full Text] [Related]
10. Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex. Limberger N; Späth L; Starke K Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):53-61. PubMed ID: 2907100 [TBL] [Abstract][Full Text] [Related]
11. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
12. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release. Zhao BG; Chapman C; Bicknell RJ Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [TBL] [Abstract][Full Text] [Related]
14. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors. Mulder AH; Hogenboom F; Wardeh G; Schoffelmeer AN J Neurochem; 1987 Apr; 48(4):1043-7. PubMed ID: 3029324 [TBL] [Abstract][Full Text] [Related]
15. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Chieng B; Christie MJ Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601 [TBL] [Abstract][Full Text] [Related]
16. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. Jackisch R; Geppert M; Illes P J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130 [TBL] [Abstract][Full Text] [Related]
17. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Jenck F; Quirion R; Wise RA Brain Res; 1987 Oct; 423(1-2):39-44. PubMed ID: 2823993 [TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists. Jackisch R; Moll S; Feuerstein TJ; Hertting G Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):105-13. PubMed ID: 2995843 [TBL] [Abstract][Full Text] [Related]
19. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane. Fedynyshyn JP; Kwiat G; Lee NM Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013 [TBL] [Abstract][Full Text] [Related]